16,402
Participants
Start Date
October 31, 2003
Primary Completion Date
July 31, 2006
Study Completion Date
June 30, 2009
ALVAC-HIV vCP1521 + AIDSVAX
Combined dose of 600 μg (300 μg of each antigen), co-formulated and administered in alumi-um hydroxide gel at a dose of 600 μg/mL
ALVAC Placebo + AIDSVAX Placebo
ALVAC carrier, supplied as a lyophilized product, without virus and Aluminum hydroxide adjuvant, 1.2 mL per vial, given as a 1 mL injection
Phan Tong District Hospital, Phan Tong District
Sattahip District Hospital, Sattahip District
Ao Udom Hospital, Sri Racha District
Provincial Health Office, Muang District
Ban Lamung District Hospital, Ban Lamung District
Ban Chang District Hospital, Ban Chang District
Ban Khai District Hospital, Ban Khai District
Klaeng District Hospital, Klaeng District
Collaborators (2)
United States Army Medical Materiel Development Activity
FED
Armed Forces Research Institute of Medical Sciences, Thailand
OTHER_GOV
Walter Reed Army Institute of Research (WRAIR)
FED
MCM Vaccines B.V.
INDUSTRY
VaxGen
INDUSTRY
The Emmes Company, LLC
INDUSTRY
Ministry of Health, Thailand
OTHER_GOV
Mahidol University
OTHER
Royal Thai Army Medical Department
OTHER_GOV
Tripler Army Medical Center
FED
Henry M. Jackson Foundation for the Advancement of Military Medicine
OTHER
U.S. Army Medical Research and Development Command
FED